Atsunobu Hiraoka

Title: Atsunobu Hiraoka: Innovator in Hematopoietic Stem Cell Research

Introduction

Atsunobu Hiraoka is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of hematopoietic stem cell research. His innovative work has the potential to impact the diagnosis and treatment of various hematopoietic diseases.

Latest Patents

Atsunobu Hiraoka holds a patent for a novel polypeptide known as the hematopoietic stem cell growth factor (SCGF). This invention provides a polypeptide that possesses growth activities on hematopoietic stem cells, along with a gene encoding the polypeptide and an antibody that specifically reacts with it. The patent also includes a method for isolating the SCGF gene and a vector for use in this method. This invention aims to elucidate the pathogenesis of hematopoietic diseases and improve the efficiency of gene transfer into hematopoietic stem cells for gene therapy applications.

Career Highlights

Throughout his career, Atsunobu Hiraoka has focused on advancing the understanding of hematopoietic stem cells. His work has contributed to the technological progress in genetic engineering, particularly in the context of bone marrow transplantation and the treatment of hematopoietic diseases.

Collaborations

Atsunobu Hiraoka has collaborated with notable colleagues, including Hiroyuki Mio and Atsushi Sugimura. These collaborations have further enhanced the impact of his research in the scientific community.

Conclusion

Atsunobu Hiraoka's innovative contributions to hematopoietic stem cell research exemplify the importance of scientific advancements in medicine. His patent on the hematopoietic stem cell growth factor represents a significant step forward in understanding and treating hematopoietic diseases.